Press Releases
> December 2008 - Goodwin Biotechnology Inc. Completes Development Of AREVA’s New Cancer Treatment > July 2008 - Goodwin Biotechnology's Manufactured Melanin-Binding Antibody Used in Successful Melanoma Trial > June 2008 - AREVA Selects Goodwin Biotechnology Inc. As a Partner for Its New Cancer Treatment > April 2008 - Goodwin Biotechnology, Inc. Completes Major Expansion Project > March 2008 - Q Therapeutics selects Goodwin Biotechnology for manufacturing of its IgM > July 2007 - Goodwin Biotechnology and Menarini Announce the Successful Completion of their Strategic US-Italian Cooperation to Fight Ovarian Cancer > June 2007 - Neogenix Oncology, Inc. Selects Goodwin Biotechnology, Inc. for Manufacturing of its Monoclonal Antibody > May 2007 - Goodwin Biotechnology Doubles GMP Manufacturing Space > October 2006 - Goodwin Biotechnology, Inc. named third fastest growing technology company > October 2006 - Caprion Pharmaceuticals Inc. and Goodwin Biotechnology, Inc. announce a manufacturing partnership for Caprion’s product to fight Shigatoxin-producing E.coli infections > January 2006 - Goodwin Biotechnology Kicks off Phase III Compliant Expansion > December 2004 - Goodwin Biotechnology, Inc. Secures Funding for Growth
Media Coverage of GBI